The safety of osmotically acting cathartics in colonic cleansing

Nature Reviews Gastroenterology and Hepatology

Volumn 7, Issue 10, 2010, Pages 557-564

  Nyberg, Caroline ^a   Hendel, Jakob ^a   Nielsen, Ole H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ASCORBIC ACID; BISACODYL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LAXATIVE; MACROGOL; MAGNESIUM CITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PICOSULFATE SODIUM; SODIUM DIHYDROGEN PHOSPHATE; SODIUM SULFATE; THIAZIDE DIURETIC AGENT;

ADJUVANT THERAPY; ALLERGIC REACTION; APHTHOUS ULCER; ASPIRATION; BIOCHEMISTRY; BLOATING; BLOOD PRESSURE; BODY WEIGHT; CLINICAL PRACTICE; COLON LAVAGE; COLONOSCOPY; COMORBIDITY; DEHYDRATION; DIARRHEA; DISEASE SEVERITY; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG ELIMINATION; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; ELDERLY CARE; ELECTROLYTE DISTURBANCE; GASTROINTESTINAL SYMPTOM; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERMAGNESEMIA; HYPERNATREMIA; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; ISCHEMIC COLITIS; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; MALLORY WEISS SYNDROME; METABOLIC DISORDER; OSMOREGULATION; PANCREATITIS; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; VOMITING;

CATHARTICS; CITRIC ACID; COLONOSCOPY; HUMANS; KIDNEY; ORGANOMETALLIC COMPOUNDS; OSMOSIS; PHOSPHATES; POLYETHYLENE GLYCOLS; WATER-ELECTROLYTE BALANCE;

EID: 77957756325     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2010.136     Document Type: Review

References (115)

1. Froehlich, F., wietlisbach, v., Gonvers, J. J., Burnand, B. & Vader, J. P. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest. Endosc. 61, 378-384 (2005).
2. Wexner, S. D. et al. A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Gastrointest. Endosc. 63, 894-909 (2006).
3. Osmotically acting laxatives WHO Collaborating Centre for Drug Statistics Methodology [online], http://www.whocc.no/atc-ddd-index/?code=A06AD (2010).
4. Barkun, A. et al. Commonly used preparations for colonoscopy: efficacy, tolerability, and safety-a Canadian Association of Gastroenterology position paper. Can. J. Gastroenterol. 20, 699-710 (2006).
5. ASGE Technology Committee, Mamula, P. et al. Colonoscopy preparation. Gastrointest. Endosc. 69, 1201-1209 (2009).
6. Worthington, J., Thyssen, M., Chapman, G., Chapman, R. & Geraint, M. A randomised controlled trial of a new 2 litre polyethylene glycol solution versus sodium picosulphate + magnesium citrate solution for bowel cleansing prior to colonoscopy. Curr. Med. Res. Opin. 24, 481-488 (2008).
7. Schanz, S. et al. Bowel preparation for colonoscopy with sodium phosphate solution versus polyethylene glycol-based lavage: a multicenter trial. Diagn. Ther. Endosc. 713521 (2008).
8. Kastenberg, D. et al. Tolerability and patient acceptance of sodium phosphate tablets compared with 4-L PEG solution in colon cleansing: combined results of 2 identically designed, randomized, controlled, parallel group, multicenter phase 3 trials. J. Clin. Gastroenterol. 41, 54-61 (2007).
9. Pelham, R. W., Nix, L. C., Chavira, R. E., Cleveland, M. v. & Stetson, P. Clinical trial: single-and multiple-dose pharmacokinetics of polyethylene glycol (PEG-3350) in healthy young and elderly subjects. Aliment. Pharmacol. Ther. 28, 256-265 (2008).
10. Rothfuss, K. S., Bode, J. C., Stange, E. F. & Parlesak, A. Urinary excretion of polyethylene glycol 3350 during colonoscopy preparation. Z. Gastroenterol. 44, 167-172 (2006).
11. Lichtenstein, G. R., Cohen, L. B. & Uribarri, J. Review article: bowel preparation for colonoscopy-the importance of adequate hydration. Aliment. Pharmacol. Ther. 26, 633-641 (2007).
12. Aljanabi, I., Johnston, P. & Stone, G. Spontaneous rupture of the oesophagus after bowel preparation with polyethylene glycol. ANZ J. Surg. 74, 176-177 (2004).
13. de Graaf, P., Slagt, C., de Graaf, J. L. & Loffeld, R. J. Fatal aspiration of polyethylene glycol solution. Neth. J. Med. 64, 196-198 (2006).
14. Hroncich, M. E. Mallory weiss tears due to colonoscopy preps. Am. J. Gastroenterol. 89, 292 (1994).
15. Hur, G. Y. et al. Aspiration pneumonia due to polyethylene glycol-electrolyte solution (Golytely) treated by bronchoalveolar lavage. Respirology 13, 152-154 (2008).
16. Marschall, H. U. & Bartels, F. Life-threatening complications of nasogastric administration of polyethylene glycol-electrolyte solutions (Golytely) for bowel cleansing. Gastrointest. Endosc. 47, 408-410 (1998).
17. Narsinghani, U., Chadha, M., Farrar, H. C. & Anand, K. S. Life-threatening respiratory failure following accidental infusion of polyethylene glycol electrolyte solution into the lung. J. Toxicol. Clin. Toxicol. 39, 105-107 (2001).
18. Paap, C. M. & Ehrlich, R. Acute pulmonary edema after polyethylene glycol intestinal lavage in a child. Ann. Pharmacother. 27, 1044-1047 (1993).
19. Pham, T., Porter, T. & Carroll, G. A case report of Boerhaave's syndrome following colonoscopy preparation. Med. J. Aust. 159, 708 (1993).
20. Santoro, M. J., Chen, Y. K. & Collen, M. J. Polyethylene glycol electrolyte lavage solution-induced Mallory-weiss tears. Am. J. Gastroenterol. 88, 1292-1293 (1993).
21. Ainley, E. J., winwood, P. J. & Begley, J. P. Measurement of serum electrolytes and phosphate after sodium phosphate colonoscopy bowel preparation: an evaluation. Dig. Dis. Sci. 50, 1319-1323 (2005).
22. Beloosesky, Y. et al. Electrolyte disorders following oral sodium phosphate administration for bowel cleansing in elderly patients. Arch. Intern. Med. 163, 803-808 (2003).
23. Casais, M. N. et al. Hyperphosphatemia after sodium phosphate laxatives in low risk patients: prospective study. World J. Gastroenterol. 15, 5960-5965 (2009).
24. Aydogan, T. et al. Fatal hyperphosphatemia secondary to a phosphosoda bowel preparation in a geriatric patient with normal renal function. J. Clin. Gastroenterol. 40, 177 (2006).
25. Azzam, I., Kovalev, Y., Storch, S. & Elias, N. Life threatening hyperphosphataemia after administration of sodium phosphate in preparation for colonoscopy. Postgrad. Med. J. 80, 487-488 (2004).
26. Boivin, M. A. & Kahn, S. R. Symptomatic hypocalcemia from oral sodium phosphate: a report of two cases. Am. J. Gastroenterol. 93, 2577-2579 (1998).
27. Ehrenpreis, E. D. et al. Serum electrolyte abnormalities secondary to Fleet's Phospho? Soda colonoscopy prep. A review of three cases. Surg. Endosc. 10, 1022-1024 (1996).
28. Ehrenpreis, E. D. et al. Symptomatic hypocalcemia, hypomagnesemia, and hyperphosphatemia secondary to Fleet's Phospho-Soda colonoscopy preparation in a patient with a jejunoileal bypass. Dig. Dis. Sci. 42, 858-860 (1997).
29. Escalante, C. P., weiser, M. A. & Finkel, K. Hyperphosphatemia associated with phosphorus-containing laxatives in a patient with chronic renal insufficiency. South. Med. J. 90, 240-242 (1997).
30. Fass, R., Do, S. & Hixson, L. J. Fatal hyperphosphatemia following Fleet Phospo? Soda in a patient with colonic ileus. Am. J. Gastroenterol. 88, 929-932 (1993).
31. Filho, A. J. & Lassman, M. N. Severe hyperphosphatemia induced by a phosphate? containing oral laxative. Ann. Pharmacother. 30, 141-143 (1996).
32. Fine, A. & Patterson, J. Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: two cases and a review of the literature. Am. J. Kidney Dis. 29, 103-105 (1997).
33. Frizelle, F. A. & Colls, B. M. Hyponatremia and seizures after bowel preparation: report of three cases. Dis. Colon Rectum 48, 393-396 (2005).
34. Liu, S. Y., Cheung, F. K., Siu, w. T. & Ng, E. K. Hyponatremic convulsion after oral sodium phosphate for bowel preparation in a patient with previous gastrectomy. Endoscopy 38, 854-855 (2006).
35. Ma, K. K. et al. Severe hyperphosphatemia and hypocalcemia following sodium phosphate bowel preparation: a forgotten menace. Endoscopy 35, 717 (2003).
36. Mishra, R., Kaufman, D., Mattern, J. III & Dutta, S. K. Severe hyperphosphatemia and hypocalcemia caused by bowel preparation for colonoscopy using oral sodium phosphate in end-stage renal disease. Endoscopy 37, 1259-1260 (2005).
37. Niemeijer, N. D., Rijk, M. C. & Van Guidener, C. Symptomatic hypocalcemia after sodium phosphate preparation in an adult with asymptomatic hypoparathyroidism. Eur. J. Gastroenterol. Hepatol. 20, 356-358 (2008).
38. Orias, M., Mahnensmith, R. L. & Perazella, M. A. Extreme hyperphosphatemia and acute renal failure after a phosphorus-containing bowel regimen. Am. J. Nephrol. 19, 60-63 (1999).
39. Shaoul, R., wolff, R., Seligmann, H., Tal, Y. & Jaffe, M. Symptoms of hyperphosphatemia, hypocalcemia, and hypomagnesemia in an adolescent after the oral administration of sodium phosphate in preparation for a colonoscopy. Gastrointest. Endosc. 53, 650-652 (2001).
40. Tan, H. L., Liew, Q. Y., Loo, S. & Hawkins, R. Severe hyperphosphataemia and associated electrolyte and metabolic derangement following the administration of sodium phosphate for bowel preparation. Anaesthesia 57, 478-483 (2002).
41. Ullah, N., Yeh, R. & Ehrinpreis, M. Fatal hyperphosphatemia from a phosphosoda bowel preparation. J. Clin. Gastroenterol. 34, 457-458 (2002).
42. Vukasin, P., Weston, L. A. & Beart, R. w. Oral Fleet Phospho-Soda laxative-induced hyperphosphatemia and hypocalcemic tetany in an adult: report of a case. Dis. Colon Rectum 40, 497-499 (1997).
43. Woo, Y. M., Crail, S., Curry, G. & Geddes, C. C. A life threatening complication after ingestion of sodium phosphate bowel preparation. BMJ 333, 589-590 (2006).
44. Holte, K., Nielsen, K. G., Madsen, J. L. & Kehlet, H. Physiologic effects of bowel preparation. Dis. Colon Rectum 47, 1397-1402 (2004).
45. Seinelä, L., Pehkonen, E., Laasanen, T. & Ahvenainen, J. Bowel preparation for colonoscopy in very old patients: a randomized prospective trial comparing oral sodium phosphate and polyethylene glycol electrolyte lavage solution. Scand. J. Gastroenterol. 38, 216-220 (2003).
46. Atkinson, R. J., Save, V. & Hunter, J. O. Colonic ulceration after sodium phosphate bowel preparation. Am. J. Gastroenterol. 100, 2603-2605 (2005).
47. Rejchrt, S. et al. A prospective, observational study of colonic mucosal abnormalities associated with orally administered sodium phosphate for colon cleansing before colonoscopy. Gastrointest. Endosc. 59, 651-654 (2004).
48. Zwas, F. R., Cirillo, N. W., El-Serag, H. B. & Eisen, R. N. Colonic mucosal abnormalities associated with oral sodium phosphate solution. Gastrointest. Endosc. 43, 463-466 (1996).
49. Aasebø, W., Scott, H. & Ganss, R. Kidney biopsies taken before and after oral sodium phosphate bowel cleansing. Nephrol. Dial. Transplant. 22, 920-922 (2007).
50. Beyea, A., Block, C. & Schned, A. Acute phosphate nephropathy following oral sodium phosphate solution to cleanse the bowel for colonoscopy. Am. J. Kidney Dis. 50, 151-154 (2007).
51. Carl, D. E. & Sica, D. A. Acute phosphate nephropathy following colonoscopy preparation. Am. J. Med. Sci. 334, 151-154 (2007).
52. Connor, A., Sykes, L., Roberts, I. S. & Weston, C. E. Acute phosphate nephropathy after sodium phosphate preparations. BMJ 337, a182 (2008).
53. Demoulin, N., Jadoul, M., Cosyns, J. P. & Labriola, L. An easily overlooked iatrogenic cause of renal failure. Clin. Nephrol. 70, 176-177 (2008).
54. Gonlusen, G., Akgun, H., Ertan, A., Olivero, J. & Truong, L. D. Renal failure and nephrocalcinosis associated with oral sodium phosphate bowel cleansing: clinical patterns and renal biopsy findings. Arch. Pathol. Lab. Med. 130, 101-106 (2006).
55. Mackey, A. C., Green, L., Amand, K. S. & Avigan, M. Sodium phosphate tablets and acute phosphate nephropathy. Am. J. Gastroenterol. 104, 1903-1906 (2009).
56. Markowitz, G. S., Stokes, M. B., Radhakrishnan, J. & D'Agati, V. D. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J. Am. Soc. Nephrol. 16, 3389-3396 (2005).
57. Ori, Y. et al. Acute phosphate nephropathy-an emerging threat. Am. J. Med. Sci. 336, 309-314 (2008).
58. Rocuts, A. K., waikar, S. S., Alexander, M. P., Rennke, H. G. & Singh, A. K. Acute phosphate nephropathy. Kidney Int. 75, 987-991 (2009).
59. Slee, T. M., Vleming, L. J. & Valentijn, R. M. Renal failure due to acute phosphate nephropathy. Neth. J. Med. 66, 438-441 (2008).
60. Steinman, T. I., Samir, A. E. & Cornell, L. D. Case records of the Massachusetts General Hospital. Case 27-2008 A 64-year-old man with abdominal pain, nausea, and an elevated level of serum creatinine. N. Engl. J. Med. 359, 951-960 (2008).
61. Markowitz, G. S., Radhakrishnan, J. & D'Agati, V. D. Towards the incidence of acute phosphate nephropathy. J. Am. Soc. Nephrol. 18, 3020-3022 (2007).
62. Ehrenpreis, E. D. Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis. Aliment. Pharmacol. Ther. 29, 1202-1211 (2009).
63. DiPalma, J. A., Buckley, S. E., warner, B. A. & Culpepper, R. M. Biochemical effects of oral sodium phosphate. Dig. Dis. Sci. 41, 749-753 (1996).
64. Marketed Health Products Directorate. Oral sodium phosphate products are no longer authorized for purgative use. Health Canada [online], http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/-2009/ oral-sodium-phos-hpc-cps-eng.php (2010).
65. Information for healthcare professionals: oral sodium phosphate (OSP) products for bowel cleansing (marketed as visicol® and OsmoPrep®, and oral sodium phosphate products available without a prescription). FDA [online], http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyinformationfor PatientsandProviders/ucm126084.htm (2010).
66. Hurst, F. P. et al. Association of oral sodium phosphate purgative use with acute kidney injury. J. Am. Soc. Nephrol. 18, 3192-3198 (2007).
67. Khurana, A., McLean, L., Atkinson, S. & Foulks, C. J. The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy. Arch. Intern. Med. 168, 593-597 (2008).
68. Russmann, S. et al. Risk of further decline in renal function after the use of oral sodium phosphate or polyethylene glycol in patients with a preexisting glomerular filtration rate below 60 ml/min. Am. J. Gastroenterol. 103, 2707-2716 (2008).
69. Singal, A. K. et al. The renal safety of bowel preparations for colonoscopy: a comparative study of oral sodium phosphate solution and polyethylene glycol. Aliment. Pharmacol. Ther. 27, 41-47 (2008).
70. Gumurdulu, Y., Serin, E., Ozer, B., Gokcel, A. & Boyacioglu, S. Age as a predictor of hyperphosphatemia after oral phosphosoda administration for colon preparation. J. Gastroenterol. Hepatol. 19, 68-72 (2004).
71. Markowitz, G. S. & Perazella, M. A. Acute phosphate nephropathy. Kidney Int. 76, 1027-1034 (2009).
72. Abaskharoun, R., Depew, W. & Vanner, S. Changes in renal function following administration of oral sodium phosphate or polyethylene glycol for colon cleansing before colonoscopy. Can. J. Gastroenterol. 21, 227-231 (2007).
73. Brunelli, S. M. et al. Risk of kidney injury following oral phosphosoda bowel preparations. J. Am. Soc. Nephrol. 18, 3199-3205 (2007).
74. Russmann, S. et al. Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am. J. Gastroenterol. 102, 2655-2663 (2007).
75. Seol, D. C. et al. Change in renal function after sodium phosphate preparation for screening colonoscopy. World J. Gastroenterol. 16, 2010-2016 (2010).
76. Korsten, M. A. et al. A prospective assessment of renal impairment after preparation for colonoscopy: oral sodium phosphate appears to be safe in well-hydrated subjects with normal renal status. Dig. Dis. Sci. 55, 2021-2029 (2010).
77. Golub, R. W. et al. Colonoscopic bowel preparations-which one? A blinded, prospective, randomized trial. Dis. Colon Rectum 38, 594-599 (1995).
78. Hookey, L. C., Depew, W. T. & Vanner, S. J. A prospective randomized trial comparing low-dose oral sodium phosphate plus stimulant laxatives with large volume polyethylene glycol solution for colon cleansing. Am. J. Gastroenterol. 99, 2217-2222 (2004).
79. Marshall, J. B., Pineda, J. J., Barthel, J. S. & King, P. D. Prospective, randomized trial comparing sodium phosphate solution with polyethylene glycol-electrolyte lavage for colonoscopy preparation. Gastrointest. Endosc. 39, 631-634 (1993).
80. Abdul-Baki, H. et al. A randomized, controlled, double-blind trial of the adjunct use of tegaserod in whole-dose or split-dose polyethylene glycol electrolyte solution for colonoscopy preparation. Gastrointest. Endosc. 68, 294-300 (2008).
81. Adams, W. J., Meagher, A. P., Lubowski, D. Z. & King, D. W. Bisacodyl reduces the volume of polyethylene glycol solution required for bowel preparation. Dis. Colon Rectum 37, 229-233 (1994).
82. Aoun, E. et al. A randomized single-blind trial of split-dose PEG-electrolyte solution without dietary restriction compared with whole dose PEG-electrolyte solution with dietary restriction for colonoscopy preparation. Gastrointest. Endosc. 62, 213-218 (2005).
83. DiPalma, J. A., wolff, B. G., Meagher, A. & Cleveland, M. Comparison of reduced volume versus four liters sulfate-free electrolyte lavage solutions for colonoscopy colon cleansing. Am. J. Gastroenterol. 98, 2187-2191 (2003).
84. DiPalma, J. A., McGowan, J. & Cleveland, M. V. Clinical trial: an efficacy evaluation of reduced bisacodyl given as part of a polyethylene glycol electrolyte solution preparation prior to colonoscopy. Aliment. Pharmacol. Ther. 26, 1113-1119 (2007).
85. El Sayed, A. M. et al. A randomized single-blind trial of whole versus split-dose polyethylene glycol-electrolyte solution for colonoscopy preparation. Gastrointest. Endosc. 58, 36-40 (2003).
86. Ell, C. et al. Randomized trial of low-volume PEG solution versus standard PEG + electrolytes for bowel cleansing before colonoscopy. Am. J. Gastroenterol. 103, 883-893 (2008).
87. Park, S. S. et al. Efficacy and tolerability of split-dose magnesium citrate: low-volume (2 liters) polyethylene glycol vs. single-or split-dose polyethylene glycol bowel preparation for morning colonoscopy. Am. J. Gastroenterol. 105, 1319-1326 (2010).
88. Sharma, V. K., Steinberg, E. N., Vasudeva, R. & Howden, C. W. Randomized, controlled study of pretreatment with magnesium citrate on the quality of colonoscopy preparation with polyethylene glycol electrolyte lavage solution. Gastrointest. Endosc. 46, 541-543 (1997).
89. Sharma, V. K. et al. Prospective, randomized, controlled comparison of the use of polyethylene glycol electrolyte lavage solution in four-liter versus two-liter volumes and pretreatment with either magnesium citrate or bisacodyl for colonoscopy preparation. Gastrointest. Endosc. 47, 167-171 (1998).
90. Ayus, J. C., Levine, R. & Arieff, A. I. Fatal dysnatraemia caused by elective colonoscopy. BMJ 326, 382-384 (2003).
91. Nagler, J., Poppers, D. & Turetz, M. Severe hyponatremia and seizure following a polyethylene glycol-based bowel preparation for colonoscopy. J. Clin. Gastroenterol. 40, 558-559 (2006).
92. Schröppel, B., Segerer, S., Keuneke, C., Cohen, C. D. & Schlöndorff, D. Hyponatremic encephalopathy after preparation for colonoscopy. Gastrointest. Endosc. 53, 527-529 (2001).
93. Ho, J. M. & Cavalcanti, R. B. A shocking bowel preparation: severe electrolyte disturbances after polyethylene glycol-based bowel preparation. J. Am. Geriatr. Soc. 57, 1729-1730 (2009).
94. Ayus, J. C. & Arieff, A. I. Pathogenesis and prevention of hyponatremic encephalopathy. Endocrinol. Metab. Clin. North Am. 22, 425-446 (1993).
95. Phillips, P. A. et al. Reduced thirst after water deprivation in healthy elderly men. N. Engl. J. Med. 311, 753-759 (1984).
96. Cohen, C. D. et al. Hyponatraemia as a complication of colonoscopy. Lancet 357, 282-283 (2001).
97. Ho, J. M., Juurlink, D. N. & Cavalcanti, R. B. Hypokalemia following polyethylene glycol-based bowel preparation for colonoscopy in older hospitalized patients with significant comorbidities. Ann. Pharmacother. 44, 466-470 (2010).
98. Antón Gironés, M., Roan, R. J., de la Hoz, B. & Sánchez, C. M. Immediate allergic reactions by polyethylene glycol 4000: two cases. Allergol. Immunopathol. (Madr.) 36, 110-112 (2008).
99. Brullet, E., Moron, A., Calvet, X., Frias, C. & Sola, J. Urticarial reaction to oral polyethylene glycol electrolyte lavage solution. Gastrointest. Endosc. 38, 400-401 (1992).
100. Franga, D. L. & Harris, J. A. Polyethylene glycolinduced pancreatitis. Gastrointest. Endosc. 52, 789-791 (2000).
101. Baudet, J. S., Castro, V. & Redondo, I. Recurrent ischemic colitis induced by colonoscopy bowel lavage. Am. J. Gastroenterol. 105, 700-701 (2010).
102. Lopez Morra, H. A., Fine, S. N. & Dickstein, G. Colonic ischemia with laxative use in young adults. Am. J. Gastroenterol. 100, 2134-2136 (2005).
103. Evans, M. D., Barton, K., Pritchard, G. A., williams, E. J. & Karandikar, S. S. Plasma magnesium should be monitored perioperatively in patients undergoing colorectal resection. Colorectal Dis. 11, 613-618 (2009).
104. Hookey, L. C. & Vanner, S. J. Pico-salax plus two-day bisacodyl is superior to pico-salax alone or oral sodium phosphate for colon cleansing before colonoscopy. Am. J. Gastroenterol. 104, 703-709 (2009).
105. Ryan, F., Anobile, T., Scutt, D., Hopwood, M. & Murphy, G. Effects of oral sodium picosulphate Picolax on urea and electrolytes. Nurs. Stand. 19, 41-45 (2005).
106. Kontani, M., Hara, A., Ohta, S. & Ikeda, T. Hypermagnesemia induced by massive cathartic ingestion in an elderly woman without pre-existing renal dysfunction. Intern. Med. 44, 448-452 (2005).
107. Onishi, S. & Yoshino, S. Cathartic-induced fatal hypermagnesemia in the elderly. Intern. Med. 45, 207-210 (2006).
108. Schelling, J. R. Fatal hypermagnesemia. Clin. Nephrol. 53, 61-65 (2000).
109. Dillon, C. E. & Laher, M. S. The rapid development of hyponatraemia and seizures in an elderly patient following sodium picosulfate/magnesium citrate (Picolax). Age Ageing 38, 487 (2009).
110. Mc Laughlin, P. et al. Bowel preparation in CT colonography: electrolyte and renal function disturbances in the frail and elderly patient. Eur. Radiol. 20, 604-612 (2010).
111. Barker, P., Trotter, T. & Hanning, C. A study of the effect of Picolax on body weight, cardiovascular variables and haemoglobin concentration. Ann. R. Coll. Surg. Engl. 74, 318-319 (1992).
112. Sanders, G. et al. Randomized clinical trial of intravenous fluid replacement during bowel preparation for surgery. Br. J. Surg. 88, 1363-1365 (2001).
113. Beck, L. H. The aging kidney. Defending a delicate balance of fluid and electrolytes. Geriatrics 55, 26-28 (2000).
114. Patel, V. et al. Intestinal and renal effects of lowvolume phosphate and sulfate cathartic solutions designed for cleansing the colon: pathophysiological studies in five normal subjects. Am. J. Gastroenterol. 104, 953-965 (2009).
115. Pelham, R. W., Alcorn, H. Jr & Cleveland, M. A pharmacokinetics evaluation of a new, lowvolume, oral sulfate colon cleansing preparation in patients with renal or hepatic impairment and healthy volunteers. J. Clin. Pharmacol. 50, 350-354 (2010).